NeuroOne Ships Initial Zimmer Biomet Order For Its Evo SEEG System For Less Than 30 Day Use
NeuroOne Ships Initial Zimmer Biomet Order For Its Evo SEEG System For Less Than 30 Day Use
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it shipped the first commercial order to Zimmer Biomet for its Evo sEEG Electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. Zimmer Biomet is the exclusive worldwide distribution partner for the NeuroOne Evo Cortical and sEEG electrode product lines.
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it shipped the first commercial order to Zimmer Biomet for its Evo sEEG Electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. Zimmer Biomet is the exclusive worldwide distribution partner for the NeuroOne Evo Cortical and sEEG electrode product lines.
NeuroOne醫療技術公司(納斯達克股票代碼：NMTC)(NeuroOne or本公司)是一家專注於改善神經系統疾病患者手術治療選擇和結果的醫療技術公司。該公司今天宣佈，已向Zimmer Biomet公司發出了第一份商業訂單，用於其Evo sEEG電極技術，暫時(不到30天)與記錄、監測和刺激設備一起使用，用於記錄、監測和刺激大腦地下水平的電信號。齊默生物科技是NeuroOne Evo Cortical和sEEG電極產品線的全球獨家分銷合作伙伴。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧